Protamine Sulfate Injection, Solution
Product Images NDC 51662-1414

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Protamine Sulfate (NDC 51662-1414). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Boxed Warning (Boxed Warning)

A text panel labeled WARNING for Protamine Sulfate injection, solution 10 mg/mL, describing serious adverse effects such as severe hypotension and cardiovascular collapse. It lists risk factors including overdose, rapid administration, prior protamine use, and specific patient conditions. It advises availability of vasopressors and resuscitation equipment and cautions against use without prior heparin.*

FDA Label Image

How Supplied (How Supplied)

A data table listing Protamine Sulfate Injection products with different NDC numbers, strengths, and packaging details, including 50 mg per 5 mL and 250 mg per 25 mL solutions, packaged in single dose flip-top vials in various quantities.*

FDA Label Image

Logo (Logo)

FDA Label Image

Serialized Labeling (Serialized Labeling)

PROTAMINE SULFATE injection, USP, 50 mg per 5 mL (10 mg per mL) in a 5 mL clear glass single dose vial with a gray rubber stopper and a white cap. The label states it is for intravenous use only and is distributed by HF Acquisition Co LLC, DBA HealthFirst. The vial label includes a barcode and other regulatory information.*

FDA Label Image

Vial 1 (Vial 1)

Protamine Sulfate Injection, USP 50 mg per 5 mL (10 mg per mL) in a 5 mL single dose vial. The label highlights that it is for intravenous use only and is labeled Rx only. The vial cap is gray with a metal seal. The labeler is HF Acquisition Co LLC, DBA HealthFirst.*

FDA Label Image

Vial 2 (Vial 2)

Clear glass vial of PROTAMINE SULFATE injection, 10 mg/mL, with a label detailing the drug's components and usage instructions. The vial has a gray rubber stopper and an aluminum seal, indicating it is for intravenous use. The product is labeled by HF Acquisition Co LLC, DBA HealthFirst.*

FDA Label Image

Vial3 (Vial 3)

A clear glass vial with a gray rubber stopper containing Protamine Sulfate injection solution. The vial label shows partial text describing its contents and storage instructions. The product is labeled by Fresenius Kabi, related to Protamine Sulfate 10 mg/mL, for intravenous use.*

FDA Label Image

Vial 4 (Vial 4)

A clear glass vial of PROTAMINE SULFATE injection, solution for intravenous use. The vial has a beige rubber stopper with a metal seal and a white label containing a barcode, lot and expiration dates, and partial manufacturing information. The strength of the solution is 10 mg/mL. The labeler is HF Acquisition Co LLC, DBA HealthFirst.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.